---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-080426"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:41:38.815379+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cerus appoints Dean Gregory to Board of Directors

## Summary
- Dean Gregory appointed to Cerus Board, effective July 1, 2024; term expires at 2027 annual meeting.
- Gregory is former President, Global Commercial Operations at Fresenius Kabi, with 30+ years in transfusion medicine.
- He receives initial RSU of 60,000 shares (3-year vest) and annual cash retainer of $45,000 under director policy.
- Gregory's industry expertise expected to support INTERCEPT Blood System expansion and manufacturing capacity growth.

## SEC filing metadata
- accession: 0000950170-24-080426
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/0000950170-24-080426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/cers-20240701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-080426
- JSON: https://secwatch.observer/filing/0000950170-24-080426.json
- Plain text: https://secwatch.observer/filing/0000950170-24-080426.txt

## Key facts
- Executive change
  Dean Gregory was appointed as Director at CERUS CORP.
  - Action: appointed
  - Role: Director
  source text: the Board extended an offer to join the Board to Dean Gregory, and on July 1, 2024, Mr. Gregory accepted such offer to join the Board, effective July 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/0000950170-24-080426-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.